TRANSFORMING THE WAY WE SEE DISEASE

Elucid Labs™ aims to democratize AI-powered point-of-care medicine by performing digital biopsy.

​We are a MedTech startup building the world's first AI-powered computational imaging device that is capable of detection and diagnosis of various diseases without the need for invasive procedures for the purposes of diagnosis and treatment planning. Currently, Elucid is building their AI dermatology assistant (AIDA™) system which provides clinical decision support as well as productivity tool to medical practitioners for early detection and non-invasive diagnosis

​of skin cancer and diseases. AIDA's patent pending computational imaging technology probes the molecular makeup of the skin at different layers and produces a 4000-parameter unique fingerprint for the lesion. AIDA's proprietary deep learning technology translates this fingerprint into valuable clinical knowledge to assist physicians in making better, faster, and well-informed decisions regarding diagnosis and course of treatment.
AS FEATURED IN:

Early detection is key to saving lives

 AIDA™ combines our digital biopsy computational Hypodermoscopy™ imager with an deep learning engine to give clinicians new insights and improve patient experience.

Efficient

Detection and diagnosis in a matter of seconds

Reduces Cost

Significantly reduces unnecessary medical procedures

Personalized Healthcare

Enables individuals to proactively participate
NEWS TIMELINE
OCT 13 2017
Spoke at Waterloo Meets AI event and joined C100 48Hrs in the Valley program
SEP 07 2017
Named by CIX as one of Canada's top 20 most innovative companies
JUN 15 2017
Featured in New York Times and Arkansas Gazette
APR 19 2017
Received funding from Spectrum28 fund
OCT 04 2017
Featured in Waterloo Chronicle article
JULY 18 2017
Joined NVIDIA Inception accelerator program
MAY 19 2017
Researchers win AI award

SOCIAL

OUR TEAM

Dr. Farnoud Kazemzadeh
Dr. Iman
​Khodadad
​Dr. Alexander
​Wong
Behnoud Kazemzadeh
Natasha
​Poley
Helmut 
​Neher
James
​Lee
Dino
​Kabiljagic​
Shahid
​Haider
Shadman
​Hassan
Aditi
​Sharma
Alessandra Urtuna
"We want machines and humans to work together, and together we can perform a lot better.”

- Farnoud Kazemzadeh, CEO of elucid labs

PUBLICATIONS

J. Arlette, Alexander Wong, Iman Khodadad, Farnoud Kazemzadeh. Deep Tissue Sequencing Using Augmented Intelligence to Probe Melanocytic Lesions. Journal of Cutaneous Medicine and Surgery. 21(6) 572. 2017. [PDF]

CAREER OPPORTUNITIES

Join Elucid Labs™ in one of the following exciting roles:

Product Development Manager
​

Contact us


​Elucid Labs, AIDA, and Hypodermoscopy are trademarks of Elucid Labs Inc.